Related Experiment Video
Updated: May 2, 2026
07:36
Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
Published on: May 1, 2015
13.8K
Lymphangiogenic factors, mechanisms, and applications
The Journal of Clinical Investigation
|March 5, 2014
Summary
Lymphangiogenesis, the growth of lymphatic vessels, is crucial for development and disease. Recent advances reveal key molecular mechanisms driving lymphatic vessel growth, offering new therapeutic strategies for diseases like cancer and lymphedema.
Area of Science:
- Vascular Biology
- Molecular Medicine
- Developmental Biology
Background:
- Lymphangiogenesis, the formation of new lymphatic vessels, plays a vital role in embryonic development.
- In adults, aberrant lymphangiogenesis is implicated in pathological conditions including lymphedema, inflammation, and cancer metastasis.
Purpose of the Study:
- To review recent advancements in understanding the molecular mechanisms of lymphangiogenesis.
- To highlight the therapeutic applications of targeting lymphangiogenesis for various human diseases.
Main Methods:
- This review synthesizes findings from recent research on lymphangiogenesis.
- Key areas explored include transcription factors, growth factor signaling pathways, and intracellular cascades involved in lymphatic vessel development.
Main Results:
- Significant progress has been made in elucidating the complex molecular pathways governing lymphangiogenesis.
- Understanding these mechanisms has identified potential therapeutic targets for diseases characterized by abnormal lymphatic vessel growth.
Conclusions:
- Targeted strategies based on recent discoveries in lymphangiogenesis mechanisms are under investigation for treating cancers, lymphedema, and preventing tissue allograft rejection.
- Continued research into lymphangiogenesis holds promise for novel therapeutic interventions in regenerative medicine and disease management.
Related Concept Videos
01:10Mechanism of Angiogenesis
6.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.4K
01:24Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
01:16Lymphatic Vessels and Lymph Transport
13.6K
Lymphatic vessels, known as lymphatics, are crucial in transporting lymph from peripheral tissues to our venous system. This process begins with lymph entering through tiny capillaries that branch through tissues. These capillaries have unique features such as larger diameters, thinner walls, and a distinctive one-way valve system formed by overlapping endothelial cells.
This one-way system allows fluids, solutes, and even pathogens to enter but prevents their return to the intercellular...
This one-way system allows fluids, solutes, and even pathogens to enter but prevents their return to the intercellular...
13.6K
01:28Functions of the Lymphatic and Immune System
6.4K
The lymphatic system plays a crucial role in bolstering our immune system. It consists of a network of lymphoid organs, lymph, and lymphatic vessels that provide structural and functional support in safeguarding the body against pathogens such as viruses and bacteria.
The primary lymphoid organs, including the bone marrow and the thymus, serve as the maturation sites for lymphocytes. Secondary lymphoid organs, like the mucosa-associated lymphoid tissue, activate these lymphocytes and serve as...
The primary lymphoid organs, including the bone marrow and the thymus, serve as the maturation sites for lymphocytes. Secondary lymphoid organs, like the mucosa-associated lymphoid tissue, activate these lymphocytes and serve as...
6.4K
01:15Development of the Lymphatic System
2.8K
The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
2.8K
01:28Role of Hematopoietic Growth Factors
3.9K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
3.9K